The Efficacy of Continued Sorafenib Treatment after Radiologic Confirmation of Progressive Disease in Patients with Advanced Hepatocellular Carcinoma.
about
Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.Combination of transcatheter arterial chemoembolization and interrupted dosing sorafenib improves patient survival in early-intermediate stage hepatocellular carcinoma: A post hoc analysis of the START trial.
P2860
The Efficacy of Continued Sorafenib Treatment after Radiologic Confirmation of Progressive Disease in Patients with Advanced Hepatocellular Carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The Efficacy of Continued Sora ...... nced Hepatocellular Carcinoma.
@ast
The Efficacy of Continued Sora ...... nced Hepatocellular Carcinoma.
@en
type
label
The Efficacy of Continued Sora ...... nced Hepatocellular Carcinoma.
@ast
The Efficacy of Continued Sora ...... nced Hepatocellular Carcinoma.
@en
prefLabel
The Efficacy of Continued Sora ...... nced Hepatocellular Carcinoma.
@ast
The Efficacy of Continued Sora ...... nced Hepatocellular Carcinoma.
@en
P2093
P2860
P1433
P1476
The Efficacy of Continued Sora ...... anced Hepatocellular Carcinoma
@en
P2093
Kazuhiro Mikagi
Masaki Tateishi
Tomoki Ryu
Yoshiyuki Wada
Yuko Takami
P2860
P304
P356
10.1371/JOURNAL.PONE.0146456
P407
P577
2016-01-08T00:00:00Z